WHO: smoking is the main cause of chronic obstructive pulmonary disease
A recent global report on Chronic Obstructive Pulmonary Disease (COPD) reveals that, despite advances in awareness about the risks of smoking, it remains one of the main causes of this deadly disease that affects more than 392 million people all over the world.
COPD, a common lung disease that causes breathing problems, claims the lives of more than 3 million people each year, according to data collected by respiratory health experts.
Highlighting the magnitude of the problem, research indicates that smoking accounts for more than 70% of COPD cases in high-income countries, while in low- and middle-income nations, this figure ranges between 30% and 40%. %, with domestic air pollution as another significant risk factor.
The risks associated with tobacco are not only limited to COPD but also increase the likelihood of developing lung cancer, cardiovascular disease, and type 2 diabetes.
Prof. David MG Halpin, consultant physician and professor of respiratory medicine, warns of the growing smoking epidemic in low- and middle-income countries, driven by the aggressive marketing strategies of tobacco companies.
“About 80% of the world’s 1.3 billion tobacco users currently live in low- and middle-income countries. “This will undoubtedly lead to a huge increase in the global burden of COPD in the coming decades,” warns the professor. Read more
2 notes
·
View notes
People Love Smoking Herbs
❤️ If you have lung issues like asthma or COPD smoking the burning cannabis leaves maybe a problem for you especially if you inhale deeply and hold it. You’re filling your lungs with far more tar than if you just puff, puff, pass and not hold it in your lungs.
Baking, however, has zero drawbacks as smoking and introduces zero harmful carcinogens into the lungs.
2 notes
·
View notes
Respiratory Medicine: Current Trends in Asthma and COPD Management
Asthma and chronic obstructive pulmonary disease (COPD) are chronic respiratory conditions that are very common, not just in people of one country but worldwide.
Though both problems are distinct, sometimes COPD is mistaken as asthma because the two have almost the same symptoms.
Below is the information that will help you differentiate both:
Asthma is a chronic inflammatory disease that affects the airways at both a cellular and molecular level. Asthmatics often suffer from allergies, and their symptoms begin in childhood.
COPD, on the other hand, is characterized by impaired airflow that cannot be reversed. It usually develops later in life.
After gaining some insight into the impact of both diseases on health, you might get concerned about the situation. But the good news is that with the increasing number of asthma and COPD patients, awareness and research for better treatment for these conditions have also increased. To ease the lives of people suffering from these issues, our scientists work day and night to create Oral and intravenous corticosteroids. Additionally, students pursuing an MD in medicine put in their 100% effort so that in the future, they can do more advanced-level research and invent new drugs.
The following are the current Asthma and COPD Management trends that you should be aware of!
Current Trends in Asthma & COPD Management
Asthma & COPD management aims to control symptoms, prevent exacerbations, and minimize the risk of persistent airflow limitation and asthma-related death.
The following are the current trends in management that you should be aware of if you are interested in studying Respiratory Medicine:
Inhalers and Nebulizers: Inhalable medications such as Fasenra, Dupixent, Ventolin, salbutamol, and terbutaline are the first-line treatments for respiratory diseases. With the advancement of medical science, the market has seen a surge in the development of more efficient and user-friendly inhaler devices, which ensure better compliance and improved drug delivery.
Despite the initial treatment, if you still struggle with the issue, consult with your doctor to pursue a second line of action.
For Asthma, second-line drugs include heliox, magnesium sulfate, ketamine, and inhalational anesthetics.
For COPD,second-line options include tiotropium, salmeterol (Serevent), formoterol (Foradil), ipratropium, albuterol/ipratropium (Combivent), and levalbuterol (Xopenex).
Biologics Medicine: The emerging trends in therapies for lung diseases have pointed toward the use of monoclonal humanized antibodies, which are referred to as biologics.
These therapies target the specific immune system components responsible for asthma and COPD, increasing the chances of better outcomes.
Digital Health Solutions: The digital revolution is not only uplifting our lifestyle but also playing a critical role in improving our health. Now, with the invention of wearable devices that can track respiratory health, patients can help themselves escape serious respiratory conditions where they have to rush to the hospital.
Personalized medicine: Another prominent trend is treatment tailored to the patient's unique genetic and molecular profile. Because every person might have different causes of problems, symptoms, and responses toward particular drugs, this approach should become more common in the coming years.
Apart from the treatment listed above, for people suffering from asthma and COPD, it is possible to manage their condition before the problem gets out of hand.
The following are the steps they can take:
Identify and avoid triggers like allergens, irritants like smoke and pollution, and respiratory infections.
Get regular vaccinations for influenza and pneumonia.
Quit Smoking
Control weight
Summary: We hope you found the above information helpful. Though the information in the article was basic, if you want in depth knowledge of the Clinical manifestation for COPD and the management of Asthma attack, enroll in our medicine md online course now!
Opt for a Medicine MD course!
This course is designed to address the gaps in clinical skills and help students grasp the subject fully.
The course covers various medical specialties, including Neurology, Cardiology, Gastrointestinal Surgery, Hepatology, Pulmonary and Chest Medicine, and rheumatology.
So, don’t wait to take a step closer to your dress, enroll in the course now!
0 notes
https://carbonfacesocial.org/blogs/69761/Asthma-And-COPD-Drugs-Market-Analysis-Size-Share-and-Forecast
The Asthma And COPD Drugs Market in 2023 is US$ 38.04 billion, and is expected to reach US$ 55.6 billion by 2031 at a CAGR of 4.90%.
FutureWise Research published a report that analyzes Asthma And COPD Drugs Market trends to predict the market's growth. The report begins with a description of the business environment and explains the commercial summary of the chain structure. Based on the market trends and driving factors presented in the report, clients will be able to plan the roadmap for their products and services taking into account various socio-economic factors.
0 notes